Search Results - Canan Alhan
- Showing 1 - 3 results of 3
-
1
Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN‐iMDS‐Flow Working Group in an independent cohort of patients with MDS Autoría: Coen R. Veenstra, Canan Alhan, Theresia M. Westers, Arjan A. van de Loosdrecht
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes Autoría: Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, Gerrit Sijm, Bouchra Badaoui, Canan Alhan, Carole Almire, Yosuke Kato, Daisuke Sakamoto, Naoko Chiba, Naho Murata, Nana Kasai, Kazuma Sei, Naoya Kawahara, Mika Ogata, Nicolas Chapuis, Orianne Wagner‐Ballon, Arjan van de Loosdrecht, Yumi Yamamoto
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Prognostic value of measurable residual disease in high‐risk MDS after intensive chemotherapy in HOVON‐SAKK studies Autoría: Coen R. Veenstra, Lok Lam Ngai, Patrycja Gradowska, Jurjen Versluis, Tom Reuvekamp, Angèle Kelder, Willemijn Scholten, Sander Snel, Jesse M. Tettero, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griskevicius, Gunnar Juliusson, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Canan Alhan, Theresia M. Westers, David C. de Leeuw, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos, Arjan A. van de Loosdrecht
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso